Differentiated Thyroid Cancer
2 competing products in clinical development for Differentiated Thyroid Cancer.
Pipeline by Phase
Pre-clinical1
Phase 21
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| LENVATINIB | Eisai | Phase 2 | Active | 39 |
| Lenvatinib | Eisai | Pre-clinical | Completed | 26 |